Drug Free Solution, Inc. (DSOL)

Drug Free Solution Income Statement

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	TTM	FY 2013	FY 2012
Period Ending	Feb 28, 2014	May 31, 2013	May 31, 2012
Cost of Revenue	0.21	0.17	0.08
Gross Profit	-0.21	-0.17	-0.08
Selling, General & Admin	0.63	0.58	0.46
Operating Expenses	0.66	0.58	0.46
Operating Income	-0.87	-0.76	-0.55
Other Non Operating Income (Expenses)	-	-	0
EBT Excluding Unusual Items	-0.87	-0.76	-0.55
Other Unusual Items	-	-	-0.08
Pretax Income	-0.87	-0.76	-0.63
Net Income	-0.87	-0.76	-0.63
Net Income to Common	-0.87	-0.76	-0.63
Shares Outstanding (Basic)	95	72	54
Shares Outstanding (Diluted)	95	72	54
Shares Change (YoY)	47.03%	32.64%	-
EPS (Basic)	-0.01	-0.01	-0.01
EPS (Diluted)	-0.01	-0.01	-0.01
Free Cash Flow	-0.76	-0.69	-0.63
Free Cash Flow Per Share	-0.01	-0.01	-0.01
EBITDA	-0.86	-0.75	-0.55
D&A For EBITDA	0	0	0
EBIT	-0.87	-0.76	-0.55

Source: S&P Global Market Intelligence. Standard template. Financial Sources.